Use of a hanging weight system for coronary artery occlusion in mice

Journal of Visualized Experiments

Volumn , Issue 50, 2011, Pages

  Eckle, Tobias ^a   Koeppen, Michael ^a   Eltzschig, Holger ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80355130068     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2526     Document Type: Article

References (54)

1. Eckle, T., Faigle, M., Grenz, A., Laucher, S., Thompson, L.F., & Eltzschig, H.K. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111:2024-2035 (2008).
2. Eckle, T., Fullbier, L., Grenz, A. & Eltzschig, H.K. Usefulness of pressure-controlled ventilation at high inspiratory pressures to induce acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 295:L718-724 (2008).
3. Eckle, T., Fullbier, L., Wehrmann, M., Khoury, J., Mittelbronn, M., Ibla, J., Rosenberger, P., & Eltzschig, H.K. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 178:8127-8137 (2007).
4. Eckle, T., Grenz, A., Laucher, S. & Eltzschig, H.K. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 118:3301-3315 (2008).
5. Eckle, T., Koeppen, M., & Eltzschig, H.K. Role of extracellular adenosine in acute lung injury. Physiology (Bethesda) 24:298-306 (2009).
6. Eckle, T., Kohler, D., Lehmann, R., El Kasmi, K., & Eltzschig, H.K. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation118:166-175 (2008).
7. Eckle, T., Kohler, D., Lehmann, R., El Kasmi, K.C., & Eltzschig, H.K. Hypoxia-Inducible Factor-1 Is Central to Cardioprotection: A New Paradigm for Ischemic Preconditioning. Circulation 118:166-175 (2008).
8. Eckle, T., Krahn, T., Grenz, A., Kohler, D., Mittelbronn, M., Ledent, C., Jacobson, M.A., Osswald, H., Thompson, L.F., Unertl, K., & Eltzschig, H.K. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115:1581-1590 (2007).
9. Eltzschig, H.K. Adenosine: an old drug newly discovered. Anesthesiology 111:904-915 (2009).
10. Eltzschig, H.K., Abdulla, P., Hoffman, E., Hamilton, K.E., Daniels, D., Schonfeld, C., Loffler, M., Reyes, G., Duszenko, M., Karhausen, J., Robinson, A., Westerman, K.A., Coe, I.R., & Colgan, S.P. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 202:1493-1505 (2005).
11. Eltzschig, H.K., Eckle, T., Mager, A., Kuper, N., Karcher, C., Weissmuller, T., Boengler, K., Schulz, R., Robson, S.C., & S.P. Colgan. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 99:1100-1108 (2006).
12. Eltzschig, H.K., Faigle, M., Knapp, S., Karhausen, J., Ibla, J., Rosenberger, P., Odegard, K.C., Laussen, P.C., Thompson, L.F., & S.P. Colgan. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108:1602-1610 (2006).
13. Eltzschig, H.K., Ibla, J.C., Furuta, G.T., Leonard, M.O., Jacobson, K.A., Enjyoji, K., Robson, S.C., & S.P. Colgan. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198:783-796 (2003).
14. Eltzschig H.K., Kohler, D., Eckle, T., Kong, T., Robson, S.C., & S.P. Colgan. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113:224-232 (2009).
15. Eltzschig, H.K., Macmanus, C.F., & S.P. Colgan. Neutrophils as Sources of Extracellular Nucleotides: Functional Consequences at the Vascular Interface. Trends Cardiovasc Med 18:103-107 (2008).
16. Eltzschig, H.K., J. Rivera-Nieves, & S.P. Colgan. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin Ther Targets 13:1267-1277 (2009).
17. Eltzschig, H.K., Thompson, L.F., Karhausen, J., Cotta, R.J., Ibla, J.C., Robson, S.C., & S.P. Colgan. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism.Blood 104:3986-3992 (2004).
18. Eltzschig, H.K., Weissmuller, T., Mager, A., & T. Eckle. Nucleotide metabolism and cell-cell interactions. Methods Mol Biol 341:73-87 (2006).
19. Frick, J.S., MacManus, C.F., Scully, M., Glover, L.E., Eltzschig, H.K., & S.P. Colgan. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol 182:4957-4964 (2009).
20. Grenz, A., Osswald, H., Eckle, T., Yang, D., Zhang, H., Tran, Z.V., Klingel, K., Ravid, K., & H.K. Eltzschig.The Reno-Vascular A2B Adenosine Receptor Protects the Kidney from Ischemia. PLoS Medicine 5:e137 (2008).
21. Grenz, A., Zhang, H., Eckle, T., Mittelbronn, M., Wehrmann, M., Kohle, C., Kloor, D., Thompson, L.F., Osswald, H., & Eltzschig, H.K. Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol 18:833-845 (2007).
22. Grenz, A., Zhang, H., Hermes, M., Eckle, T., Klingel, K., Huang, D.Y., Muller, C.E., Robson, S.C., Osswald, H., & Eltzschig, H.K. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J21:2863-2873 (2007).
23. Grenz, A., Zhang, H., Weingart, J., S. von Wietersheim, Eckle, T., Schnermann, J.B., Kohle, C., Kloor, D., Gleiter, C.H., Vallon, V., Eltzschig, H.K., & H. Osswald. Lack of effect of extracellular adenosine generation and signalling on renal erythropoietin secretion during hypoxia. Am J Physiol Renal Physiol 00243.02007 (2007).
24. Hart, M.L., Gorzolla, I.C., Schittenhelm, J., Robson, S.C., & Eltzschig, H.K. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol 184:4017-4024 (2010).
25. Hart, M.L., Henn, M., Kohler, D., Kloor, D., Mittelbronn, M., Gorzolla, I.C., Stahl, G.L., & Eltzschig, H.K. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J22:2784-2797 (2008).
26. Hart, M.L., Jacobi, B., Schittenhelm, J., Henn, M., & Eltzschig, H.K. Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol182:3965-3968 (2009).
27. Hart, M.L., Kohler, D., Eckle, T., Kloor, D., Stahl, G.L., & Eltzschig, H.K. Direct treatment of mouse or human blood with soluble 5'-nucleotidase inhibits platelet aggregation. Arterioscler Thromb Vasc Biol 28:1477-1483 (2008).
28. Hart, M.L., Much, C., Gorzolla, I.C., Schittenhelm, J., Kloor, D., Stahl, G.L., & Eltzschig, H.K. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 135:1739-1750 e1733 (2008).
29. Koeppen, M., Eckle, T., & Eltzschig, H.K. Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo. PLoS One 4:e6784 (2009).
30. Kohler, D., Eckle, T., Faigle, M., Grenz, A., Mittelbronn, M., Laucher, S., Hart, M.L., Robson, S.C., Muller, C.E., & Eltzschig, H.K. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116:1784-1794 (2007).
31. Kong, T., Westerman, K.A., Faigle, M., Eltzschig, H.K., & S.P. Colgan. HIF-dependent induction of adenosine A2B receptor in hypoxia. Faseb J 20:2242-2250 (2006).
32. Loffler, M., J.C. Morote-Garcia, Eltzschig, S.A., Coe, I.R., & Eltzschig, H.K. Physiological roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol 27:1004-1013 (2007).
33. Morote-Garcia, J.C., Rosenberger, P., Kuhlicke, J., & Eltzschig, H.K. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111:5571-5580 (2008).
34. Morote-Garcia, J.C., Rosenberger, P., Nivillac, N.M., Coe, I.R., & Eltzschig, H.K. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia.Gastroenterology136:607-618 (2009).
35. Reutershan, J., Vollmer, I., Stark, S., Wagner, R., Ngamsri, K.C., & Eltzschig, H.K. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J 23:473-482 (2009).
36. Schingnitz, U., Hartmann, K., Macmanus, C.F., Eckle, T., Zug, S., Colgan, S.P., & Eltzschig, H.K. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 184:5271-5279 (2010).
37. Synnestvedt, K., Furuta, G.T., Comerford, K.M., Louis, N., Karhausen, J., Eltzschig, H.K., Hansen, K.R., Thompson, L.F., & S.P. Colgan. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110:993-1002 (2002).
38. Thompson, L.F., Eltzschig, H.K., Ibla, J.C., C.J. Van De Wiele, Resta, R., J.C. Morote-Garcia, & S.P. Colgan. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200:1395-1405 (2004).
39. Eckle, T., Grenz, A., Kohler, D., Redel, A., Falk, M., Rolauffs, B., Osswald, H., Kehl, F., & Eltzschig, H.K. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 291:H2533-2540 (2006).
40. Redel, A., Jazbutyte, V., Smul, T.M., Lange, M., Eckle, T., Eltzschig, H., Roewer, N., & F. Kehl. Impact of ischemia and reperfusion times on myocardial infarct size in mice in vivo. Exp Biol Med (Maywood) 233:84-93 (2008).
41. Warth, A., Eckle, T., Kohler, D., Faigle, M., Zug, S., Klingel, K., Eltzschig, H.K., & H. Wolburg. Upregulation of the water channel aquaporin-4 as a potential cause of postischemic cell swelling in a murine model of myocardial infarction. Cardiology107:402-410 (2007).
42. Dewald, O., Frangogiannis, N.G., Zoerlein, M.P., Duerr, G.D., Taffet, G., Michael, L.H., Welz, A., & M.L. Entman. A murine model of ischemic cardiomyopathy induced by repetitive ischemia and reperfusion. Thorac Cardiovasc Surg 52:305-311 (2004).
43. Ito, W.D., Schaarschmidt, S., Klask, R., Hansen, S., Schafer, H.J., Mathey, D., & S. Bhakdi. Infarct size measurement by triphenyltetrazolium chloride staining versus in vivo injection of propidium iodide. J Mol Cell Cardiol 29:2169-2175 (1997).
44. Schwanke, U., Konietzka, I., Duschin, A., Li, X., Schulz, R., & G. Heusch. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 283:H1740-1742 (2002).
45. Fisher, S.G., & Marber, M.S. An in vivo model of ischaemia-reperfusion injury and ischaemic preconditioning in the mouse heart. J Pharmacol Toxicol Methods 48:161-169 (2002).
46. Bickler, P.E., Zhan, X., Fahlman, C.S. Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology 103: 532-539 (2005).
47. Chiari, P., Piriou, V., Hadour, G., Rodriguez, C., Loufouat, J., et al. Preservation of ischemia and isoflurane-induced preconditioning after brain death in rabbit hearts. Am J Physiol Heart Circ Physiol 283: H1769-1774 (2002).
48. Ebel, D., Mullenheim, J., Sudkamp, H., Bohlen, T., Ferrari, J., et al. Role of tyrosine kinase in desflurane- Induced preconditioning. Anesthesiology 100: 555-561 (2004).
49. Hanouz, J.L., Yvon, A., Massetti, M., Lepage, O., Babatasi, G., et al. Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. Anesthesiology 97: 33-41 (2002).
50. Kersten, J.R., Schmeling, T.J., Pagel, P.S., Gross, G.J., Warltier, D.C. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 87: 361-370 (1997).
51. Mullenheim, J., Ebel, D., Frassdorf, J., Preckel, B., Thamer, V., et al. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 96: 934-940 (2002).
52. Redel, A., Stumpner, J., Tischer-Zeitz, T., Lange, M., Smul, T.M., et al. Comparison of isoflurane-, sevoflurane-, and desflurane-induced preand postconditioning against myocardial infarction in mice in vivo. Exp Biol Med (Maywood) 234: 1186-1191 (2009).
53. Toller, W.G., Kersten, J.R., Gross, E.R., Pagel, P.S., Warltier, D.C. Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology 92: 1400-1407 (2000).
54. Weber, N.C., Toma, O., Awan, S., Frassdorf, J., Preckel, B., et al. Effects of nitrous oxide on the rat heart in vivo: another inhalational anesthetic that preconditions the heart? Anesthesiology 103: 1174-1182 (2005).